D10AD54 • isotretinoin + erythromycin • Dermatologicals | Anti-acne preparations for topical use | Retinoids for topical use in acne
The combination of isotretinoin and erythromycin is used to treat moderate to severe acne. Isotretinoin reduces sebum production and inflammation, while erythromycin is an antibiotic that targets bacteria associated with acne.
The medication is available as a gel or cream and is applied topically to affected areas, usually once or twice daily, as directed by a doctor.
Side effects may include local irritation, dryness, or redness of the skin. In rare cases, severe allergic reactions may occur.
Patients should avoid prolonged sun exposure and use sunscreen. Pregnant or breastfeeding women should consult a specialist before use.
Substance: isotretinoin + erythromycin
Date of last drug list: 01-07-2021
Commercial code: W56787001
Concentration: 0.5mg / 20mg / g
Pharmaceutical form: gel
Quantity: 1
Product type: generic
Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.
Manufacturer: STIEFEL LABORATORIES (IRELAND) LTD. - IRLANDA
Holder: GLAXOSMITHKLINE (GSK) S.R.L. - ROMANIA
Number: 5856/2013/01
Shelf life: 18 months